David J. Mazzo
Chief Executive Officer at Lisata Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Lisata Therapeutics Inc., 3 years.
Lisata Therapeutics Inc.
Director · President & CEO
Chief executive roles
Lisata Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 2026 | Lisata Therapeutics Inc. | Grant or award | +81,000 | — | — |
| Jan 9, 2026 | Lisata Therapeutics Inc. | Shares withheld for tax | −10,503 | $1.97 | $20,691 |
| Jan 9, 2026 | Lisata Therapeutics Inc. | Shares withheld for tax | −10,515 | $1.97 | $20,715 |
| Jan 9, 2026 | Lisata Therapeutics Inc. | Shares withheld for tax | −12,224 | $1.97 | $24,081 |
| Jan 9, 2026 | Lisata Therapeutics Inc. | Shares withheld for tax | −7,854 | $1.97 | $15,472 |
| Jan 10, 2025 | Lisata Therapeutics Inc. | Shares withheld for tax | −3,106 | $3.73 | $11,585 |
| Jan 9, 2025 | Lisata Therapeutics Inc. | Grant or award | +81,000 | — | — |
| Jan 9, 2025 | Lisata Therapeutics Inc. | Shares withheld for tax | −9,414 | $3.80 | $35,773 |
| Jan 9, 2025 | Lisata Therapeutics Inc. | Shares withheld for tax | −10,925 | $3.80 | $41,515 |
| Jan 9, 2025 | Lisata Therapeutics Inc. | Shares withheld for tax | −7,017 | $3.80 | $26,665 |
| Oct 1, 2024 | Lisata Therapeutics Inc. | Grant or award | +58,000 | $2.93 | $169,940 |
| Oct 1, 2024 | Lisata Therapeutics Inc. | Shares withheld for tax | −26,964 | $2.93 | $79,005 |
| Jan 11, 2024 | Lisata Therapeutics Inc. | Shares withheld for tax | −1,026 | $2.99 | $3,068 |
| Jan 10, 2024 | Lisata Therapeutics Inc. | Shares withheld for tax | −3,470 | $3.00 | $10,410 |
| Jan 9, 2024 | Lisata Therapeutics Inc. | Grant or award | +94,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.